Literature DB >> 34654472

Efficacy of probiotics in the prevention of diarrhea in ventilated critically ill ICU patients: meta-analysis of randomized control trials: author's reply.

Priyam Batra1, Kapil Dev Soni2, Purva Mathur3.   

Abstract

Entities:  

Year:  2021        PMID: 34654472      PMCID: PMC8517294          DOI: 10.1186/s40560-021-00578-0

Source DB:  PubMed          Journal:  J Intensive Care        ISSN: 2052-0492


× No keyword cloud information.
Sir, I thank Shimizu et al. for their interest in our paper entitled “Efficacy of probiotics in the prevention of VAP in critically ill ICU patients: an updated systematic review and meta-analysis of randomized control trials” [1]. We are thankful to the authors for their valuable re-analysis of our meta-analysis and bringing forth the additional advantage of diarrhea prevention in ventilated patients by the use of probiotics. We agree that we missed inclusion of their valuable study entitled “Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial” [2] while performing the forest plot analysis of the incidence of diarrhea in ventilated ICU patients. Both the reviewers again analyzed the data and found that as the authors had used the word “enteritis” and “loose stools” in their paper in place of “diarrhea” the study was missed in the analysis. Most previous meta-analysis such as by Su et al. and Johnstone et al. [3, 4]have missed this important finding. A recently published randomized control study by Johnstone et al. [5] showed that there was no significant difference in diarrhea between patients in the probiotic group vs placebo group. Thus, we re-assessed the meta-analysis after adding this study also to our meta-analysis (as shown in Fig. 1). The effect was seen on a total of 3176 patients (1582 probiotic group vs 1594 placebo group). Moderate heterogeneity (OR 0.63, CI 0.38, 1.04; P = 0.07; I2 = 65%) was seen between the studies. After adding this study, it can be seen that the trend favors probiotics in reducing the risk of diarrhea in ventilated patients though the effect is not statistically significant.
Fig. 1

A forest plot of the incidence of diarrhea

A forest plot of the incidence of diarrhea The use of probiotics has been well known to be associated with the reduction of C. difficile-associated diarrhea as supported by Goldenberg et al. [6] and Gokalani et al. [7]. This additional knowledge of the role of probiotics in prevention of diarrhea in ventilated patients is valuable and would encourage most clinicians in the use of probiotics in all ventilated ICU patients.
  6 in total

1.  Probiotics for the Prevention of Ventilator-Associated Pneumonia: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Minmin Su; Ying Jia; Yan Li; Dianyou Zhou; Jinsheng Jia
Journal:  Respir Care       Date:  2020-03-03       Impact factor: 2.258

Review 2.  Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.

Authors:  Joshua Z Goldenberg; Christina Yap; Lyubov Lytvyn; Calvin Ka-Fung Lo; Jennifer Beardsley; Dominik Mertz; Bradley C Johnston
Journal:  Cochrane Database Syst Rev       Date:  2017-12-19

3.  Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial.

Authors:  Jennie Johnstone; Maureen Meade; François Lauzier; John Marshall; Erick Duan; Joanna Dionne; Yaseen M Arabi; Diane Heels-Ansdell; Lehana Thabane; Daphnee Lamarche; Michael Surette; Nicole Zytaruk; Sangeeta Mehta; Peter Dodek; Lauralyn McIntyre; Shane English; Bram Rochwerg; Tim Karachi; William Henderson; Gordon Wood; Daniel Ovakim; Margaret Herridge; John Granton; M Elizabeth Wilcox; Alberto Goffi; Henry T Stelfox; Daniel Niven; John Muscedere; François Lamontagne; Frédérick D'Aragon; Charles St-Arnaud; Ian Ball; Dave Nagpal; Martin Girard; Pierre Aslanian; Emmanuel Charbonney; David Williamson; Wendy Sligl; Jan Friedrich; Neill K Adhikari; François Marquis; Patrick Archambault; Kosar Khwaja; Arnold Kristof; James Kutsogiannis; Ryan Zarychanski; Bojan Paunovic; Brenda Reeve; François Lellouche; Paul Hosek; Jennifer Tsang; Alexandra Binnie; Sébastien Trop; Osama Loubani; Richard Hall; Robert Cirone; Steve Reynolds; Paul Lysecki; Eyal Golan; Rodrigo Cartin-Ceba; Robert Taylor; Deborah Cook
Journal:  JAMA       Date:  2021-09-21       Impact factor: 56.272

Review 4.  Efficacy of probiotics in the prevention of VAP in critically ill ICU patients: an updated systematic review and meta-analysis of randomized control trials.

Authors:  Priyam Batra; Kapil Dev Soni; Purva Mathur
Journal:  J Intensive Care       Date:  2020-10-15

5.  Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial.

Authors:  Kentaro Shimizu; Tomoki Yamada; Hiroshi Ogura; Tomoyoshi Mohri; Takeyuki Kiguchi; Satoshi Fujimi; Takashi Asahara; Tomomi Yamada; Masahiro Ojima; Mitsunori Ikeda; Takeshi Shimazu
Journal:  Crit Care       Date:  2018-09-27       Impact factor: 9.097

6.  Evaluating probiotics for the prevention of ventilator-associated pneumonia: a randomised placebo-controlled multicentre trial protocol and statistical analysis plan for PROSPECT.

Authors:  Jennie Johnstone; Diane Heels-Ansdell; Lehana Thabane; Maureen Meade; John Marshall; Francois Lauzier; Erick Huaileigh Duan; Nicole Zytaruk; Daphnee Lamarche; Michael Surette; Deborah J Cook
Journal:  BMJ Open       Date:  2019-06-20       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.